| Name | hydroxyurea |
|---|---|
| Synonyms |
hydroxycarbamide
HYDROXYUREA (HYDROXYCARBAMIDE) HYDROXYUREA 127-07-1 Hydroxyurea Droxia HYDROXYCARBAMIDE, BP STANDARD HYDROXYHARNSTOFF amino-hydroxamic acid Hydrea HYDROXYHARNSTOFF(HYDROXYUREA) 1-hydroxyure hydroxyl urea Hydroxy urea HYDROXYCARBAMIDE (HYDROXYUREA) MFCD00007943 Urea, N-hydroxy- Onco-carbide Oxyurea N-HYDROXYUREA EINECS 204-821-7 Litalir 1-Hydroxyurea Biosupressin hydroxyure |
| Description | Hydroxyurea is a cell apoptosis inducer that inhibitDNA synthesis through inhibition of ribonucleotide reductase. |
|---|---|
| Related Catalog | |
| In Vitro | Hydroxyurea is used in a number of myeloproliferative, neoplastic, HIV, and non-hematological diseases[1]. Treatment of cells in primary culture with 30 μM hydroxyurea for 96 hours significantly increases the fractional HbF content. The Gγ: Aγ-globin mRNA is induced 0.30- to 8-fold in vitro[2]. Hydroxyurea has been shown to block HIV-1 reverse transcription and/or replication in quiescent peripheral blood mononuclear cells and macrophages[3]. |
| In Vivo | Hydroxyurea therapy producs consistent reductions in WBC and ANC without improvement in anemia over 17 weeks. Hydroxyurea at 50mg/kg produces a reduced white blood cell count, absolute neutrophil count and no improvement in anemia compared to vehicle treated sickle cell mice[4]. |
| Animal Admin | Mice: To determine whether hydroxyurea would improve anemia and/or prevent or diminish the development of organ damage in the absence of HbF induction, hydroxyurea, at doses of 25 mg/kg, 50 mg/kg, and 100 mg/kg, or vehicle is administered five days per week to SCD mice[4]. |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 222.1±23.0 °C at 760 mmHg |
| Melting Point | 135-140 °C |
| Molecular Formula | CH4N2O2 |
| Molecular Weight | 76.055 |
| Flash Point | 88.1±22.6 °C |
| Exact Mass | 76.027275 |
| PSA | 75.35000 |
| LogP | -1.80 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.501 |
| Storage condition | 2-8°C |
| Water Solubility | soluble |
| Symbol |
GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H340-H361 |
| Precautionary Statements | P201-P280-P308 + P313 |
| Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
| Hazard Codes | T:Toxic |
| Risk Phrases | R46;R61 |
| Safety Phrases | S53-S36/37-S45 |
| RIDADR | 2811 |
| WGK Germany | 3 |
| RTECS | YT4900000 |
| Packaging Group | III |
| HS Code | 2928000090 |
| Precursor 9 | |
|---|---|
| DownStream 10 | |
| HS Code | 2924199090 |
|---|---|
| Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |